Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904

スポンサーリンク

概要

• 論文の詳細を見る
• 2001-02-25

著者

• Barrett D

  Fujisawa Pharmaceutical Co. Ltd. Osaka Jpn

• Barrett David

  Medicinal Chemistry Research Laboratories

• Fujie Akihiko

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• HASHIMOTO MICHIZANE

  Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd

• FUJIE Akihiko

  Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.

• HASHIMOTO Seiji

  Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.

• Tanaka A

  Institute For Drug Discovery Research Yamanouchi Pharmaceutical Co. Ltd.

• SHIGEMATSU Nobuharu

  Exploratory Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.,

• Hashimoto Michizane

  Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.

• Hashimoto Michizane

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• TANAKA Akira

  Medicinal Chemistry Research Laboratories

• IKEDA Fumiaki

  Medicinal Biology Research Laboratories

• Barrett David

  New Drug Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Ikeda F

  Pharmacology Research Laboratories Astellas Pharma Inc.

• Hashimoto Seiji

  Fermentation Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Fujie Akihiko

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Shigematsu Nobuharu

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Hino Motohiro

  Fermentation Research Laboratories Drug Discovery Research Astellas Pharma Inc.

• Hashimoto Seiji

  Department Of Biotechnology Toyama Prefectural University

• Hashimoto Seiji

  Department Of Nephrology Sapporo City General Hospital

• Tanaka A

  Department Of Emergency Medicine Kyoto University Hospital

• Hashimoto Seiji

  Exploratory Research Laboratories Fujisawa Pharmaceutical Co. Ltd.

• Shigematsu Nobuharu

  Exploratory Research Division Astellas Research Technologies

関連論文

• YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : II. Physico-chemical Properties and Structure Elucidation
• YM-216391, a Novel Cytotoxic Cyclic Peptide from Streptomyces nobilis : I. Fermentation, Isolation and Biological Activities
• YM-181741, a Novel Benz[a]anthraquinone Antibiotic with Anti-Helicobacter pylori Activity from Streptomyces sp.
• γ-Pyrone Compounds with Selective and Potent Anti-Helicobacter pylori Activity
• 1P039 抗生物質代謝酵素の基質結合シミュレーション(蛋白質-構造機能相関,第48回日本生物物理学会年会)
• The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No. 19353 : II. Biological Profiles
• A Multidimensional Cubic-Interpolated Pseudoparticle (CIP) Method Without Time Splitting Technique for Hyperbolic Equations
• Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations
• Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
• Naphthalecin, a Novel Antibiotic Produced by the Anaerobic Bacterium, Sporotalea colonica sp. nov.
• Tumor thrombi in the portal vein system originating from gastrointestinal tract cancer
• Treatment of ruptured hepatocellular carcinoma
• FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : II. Biological Profiles
• FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919 : I. Taxonomy of the Producing Organism, Fermentation, Islation and Physico-chemical Properties
• FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : II. Biological Activities
• FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minima No. 15604 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
• The Novel Gluconeogenesis Inhibitors FR225659 and Related Compounds that Originate from Helicomyces sp. No.19353 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) II. Biological Activities in Animal Models
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 III. In Vivo Activities
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase (HDAC) I. Taxonomy, Fermentation, Isolation and Biological Activities
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 II. In Vitro Property and Mode of Action
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : II. In Vitro and In Vivo Activities
• Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescence
• Unilateral renal cortical necrosis with contralateral hydronephrosis after surgery for uterus carcinoma
• Rapidly Progressive Renal Failure Occurring in the Course of Pyoderma Gangrenosum and IgA (λ) Monoclonal Gammopathy
• Total Synthesis of WS9326A, a Potent Tachykinin Antagonist from Streptomyces violaceoniger
• FR227673 and FR190293, Novel Antifungal Lipopeptides from Chalara sp. No. 22210 and Tolypocladium parasiticum No. 16616
• FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : I. Taxonomy, Fermentation, and Biological Properties
• FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : II. Biological Properties and Model of Action
• FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase III. Structure Determination
• A New Antimitotic Substance, FR182877 : II. The Mechanism of Action
• Novel Amidine Conjugates of the Ornithine Moiety of the Macrocyclic Antifungal Lipopeptidolactone FR901469
• Site-specific Structural Transformation of the Novel Antifungal Cyclic Depsipeptide FR901469 : Synthesis and Biological Activity of FR203904
• FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : II. In Vitro and In Vivo Antifungal Activity
• FR227244, a Novel Antifungal Antibiotic from Myrothecium cinctum No. 002 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243 : III. Structure Determination
• FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No.11243 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• FR198248, a New Anti-influenza Agent isolated from Aspergillus terreus No.13830 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• FR901483, a Novel Immunosuppressant Isolated from Cladobotryum sp. No. 11231 Taxonomy of the Producing Organism, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• Severe complications of mediastinal pancreatic pseudocyst : report of esophagobronchial fistula and hemothorax
• Extreme discrepancy between macroscopic diagnosis and pathological findings of gallbladder cancer treated by hepatopancreatoduodenectomy
• Extrahepatic large hepatocellular carcinoma with peritoneal dissemination : multimodal treatment, including four surgical operations
• FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 : II. Isolation and Structure Elucidation
• Alkylation of 1-[N-(Hydroxymethyl)-N-methylamino]-4-quinolomes. An Improved Preparation of Intermediates for Novel Potent Tricyclic Quinolone Antibacterial Agents
• Oxidative Activities of Heterologously Expressed CYP107B1 and CYP105D1 in Whole-Cell Biotransformation Using Streptomyces lividans TK24(ENZYMOLOGY, PROTEIN ENGINEERING, AND ENZYME TECHNOLOGY)
• The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : II. Biological Activities
• The Novel Gluconeogenesis Inhibitor FR225654 that Originates from Phoma sp. No. 00144 : I. Taxonomy, Fermentation, Isolation and Physico-chemical Properties
• The Novel Gluconeogenesis Inhibitors FR225659 and FR225656 from Helicomyces sp. No. 19353 : III. Structure Determination
• FR252921, a Novel Immunosuppressive Agent Isolated from Pseudomonas fluorescens No.408813 I. Taxonomy, Ferimentation, Isolation, Physico-chemical Properties and Biological Activities of FR252921, FR252922 and FR256523
• New Anti-influenza Agents, FR198248 and Its Derivatives : II. Characterization of FR198248, Its Related Compounds and Some Derivatives
• FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : II. Biological Properties
• FR191512 , a Novel Anti-influenza Agent Isolated from a Fungus Strain No.17415 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Structure Elucidation
• WA8242A_1, A_1 and B, Novel Secretory Phospholipase A_1 Inhibitors Produced by Streptomyces violaceusniger I. Taxonomy, Production and Purification
• FR225659-binding Proteins : Identification as Serine/Threonine Protein Phosphatase PP1 and PP2A Using High-performance Affinity Beads
• A Comparative Study of Malaysian and Japanese Actinomycetes Using a Simple Identification Method Based on Partial 16S rDNA Sequence
• A New Antimitotic Substance, FR182877 : I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Activities
• The Arabidopsis-accelerated cell death gene ACD1 is involved in oxygenation of pheophorbide a: inhibition of the pheophorbide a oxygenase activity does not lead to the "stay-green" phenotype in Arabidopsis
• Pulmonary Hyalinizing Granuloma with Hydronephrosis
• WF14865A and B, New Cathepsins B and L Inhibitors Produced by Aphanoascus fulvescens I. Taxonomy, Production, Purification and Biological Properties
• WF14861, a New Cathepsins B and L Inhibitor Produced by Colletotrichum sp. I. Taxonomy, Production Purification and Structure Elucidation
• Studies on β-Lactam Antibiotics Synthesis and Antibacterial Activity of Novel C-3 Alkyne-substituted Cephalosporins
• WF14861, a New Cathepsins B and L Inhibitor Produced by Collectotrichum sp. II. Biological Properties
• WA8242A_1, A_2 and B, Novel Secrtory Phospholipase A_2 Inhibitors Produced by Streptomyces violaceusniger II. Biological Properties
• Antifungal Mechanism of FK463 against Candida albicans and Aspergillus fumigatus
• Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds
• Identification of Flexible Structures : a Gray Box Approach
• DVFC-Based Identification and Its Application to Robust Vibration Suppression Control of Flexible Structures
• Epimerization Induced by a Remote Cationic Center in Potent New Carbapenems
• Bubble Splitting by Turbulent Jet Emitted from Orifice
• Strain selection and scale-up fermentation for FR901379 acylase production by Streptomyces sp. no. 6907(METHOD)
• Cloning and expression of the FR901379 acylase gene from Streptomyces sd. no. 6907
• Anti-herpes virus activity of polyether antibiotic CP-44161 in vivo
• Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
• Screening and characterization of microorganisms with FR901379 acylase activity
• AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
• Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
• Bioconversion of AS1387392 : bioconversion studies involving Amycolatopsis azurea JCM 3275
• Bioconversion of AS1387392 : screening and characterization of actinomycetes that convert AS1387392 to AS1429716
• A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease
• Sapphirine from Metamorphosed Layered Complex of Mt. Poroshiri, Hidaka Metamorphic Belt, Hokkaido

もっと見る 閉じる

スポンサーリンク